MS

Phase III Data Mixed on Sanofi's Lemtrada
Yahoo/Zacks.com
Wed, 07/13/11 - 06:25 pm
Sanofi
Lemtrada
MS
multiple sclerosis
alemtuzumab
Sanofi-Genzyme MS Drug: Mixed Results
TheStreet.com
Mon, 07/11/11 - 09:50 am
MS
multiple sclerosis
Sanofi
Genzyme
Questcor hits 52-week high
Marketwatch
Mon, 07/4/11 - 09:18 am
Questcor Pharmaceuticals
MS
multiple sclerosis
Acthar
Merck Says Submits Application for MS Treatment Rebif in Europe
Bloomberg
Wed, 06/29/11 - 06:54 am
Merck
Rebif
MS
Europe
multiple sclerosis
Acorda Pushes Sales of MS Drug
Minyanville
Wed, 06/29/11 - 12:07 am
Acorda Therapeutics
MS
multiple sclerosis
AMPYRA
With cladribine gone, Gilenya takes center stage
Fierce Pharma
Wed, 06/22/11 - 07:35 pm
Gilenya
cladribine
Movectro
MS
multiple sclerosis
Novartis
Merck KGaA
Merck KGaA Slides After Decision Not to Seek MS Drug Approval
Bloomberg
Wed, 06/22/11 - 08:16 am
MS
multiple sclerosis
Merck KGaA
cladribine
Mylan wins on summary judgment
Bizjournals.com
Mon, 06/20/11 - 09:27 am
Mylan
Teva Pharmaceuticals
MS
multiple sclerosis
Copaxone
Analyst raises Acorda target as Ampyra sales grow
Yahoo/AP
Mon, 06/13/11 - 06:11 pm
AMPYRA
Acorda Therapeutics
MS
Biogen Idec
multiple sclerosis
FDA postpones ruling on generic Copaxone
Globes, Israel
Thu, 06/9/11 - 08:06 am
FDA
generics
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Biogen Seeking Deals to Expand Pipeline of MS Treatments
Bloomberg
Wed, 06/8/11 - 08:53 am
MS
multiple sclerosis
Biogen Idec
Biogen says European Union regulators approved once-a-week injection pen for MS
Yahoo/AP
Tue, 06/7/11 - 09:54 am
Biogen Idec
Europe
MS
multiple sclerosis
Avonex pen
Teva begins new double-dose Copaxone trial
Globes, Israel
Thu, 06/2/11 - 10:45 am
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Novartis’s Gilenya MS Drug Has 10,000 Users in U.S., Mundel Says
Bloomberg
Wed, 05/25/11 - 11:34 am
Novartis
MS
Gilenya
multiple sclerosis
CHMP Backs Biogen's Fampyra
Yahoo/Zacks.com
Tue, 05/24/11 - 08:28 am
Biogen Idec
Fampyra
CHMP
MS
multiple sclerosis
FDA: Tysabri risks greatest during year 3
Fierce Pharma
Tue, 04/26/11 - 06:21 am
FDA
Biogen Idec
Tysabri
MS
multiple sclerosis
XenoPort plans study on potential MS drug
Yahoo/AP
Mon, 04/25/11 - 11:17 am
MS
XenoPort
multiple sclerosis
arbaclofen placarbil
Biogen surges on data for MS oral drug candidate
Yahoo/AP
Fri, 04/22/11 - 08:34 am
MS
multiple sclerosis
Biogen Idec
BG-12
Biogen’s 'Avonex Pen' wins tentative EU nod
Bizjournals.com
Tue, 04/19/11 - 11:18 am
Biogen Idec
Avonex
MS
multiple sclerosis
Europe
Avonex pen
EU Panel Recommends That Elan Update Tysabri MS Drug Label
Bloomberg
Mon, 04/18/11 - 10:59 am
Europe
Elan
MS
multiple sclerosis
Tysabri

Pages